Identification of a novel PANoptosis-related gene signature for predicting the prognosis in clear cell renal cell carcinoma

Dezhi Yue,Congzhe Ren,Hu Li,Xiaoqiang Liu
DOI: https://doi.org/10.1097/md.0000000000039874
IF: 1.6
2024-09-29
Medicine
Abstract:Renal cell carcinoma (RCC), which is considered to be one of the most prevalent tumors in urinary system, exhibits highly malignant and lethal characteristics. [ 1 ] According to the statistics in 2020, more than 430,000 RCC cases were newly diagnosed and nearly 200,000 deaths occurred worldwidely. [ 2 ] This indicated RCC has become a serious threat globally. With asymptomatic feature in the early stages, 1⁄4 to 1⁄3 of RCC patients have missed the optimal opportunity for treatment because of distant metastases having occurred when diagnosed. [ 3 ] As the most common histopathological subtype, clear cell renal cell carcinoma (ccRCC) is responsible for up to 75% in RCC patients. [ 4 ] It has been confirmed that ccRCC is of high tumor heterogeneity and rather aggressive. [ 5 ] With great advances in treatment methods, alternative therapies, such as surgery, immunotherapy and targeted therapy, have made major breakthroughs. [ 6 ] However, the prognosis and progression-free survival of patients in late stages remain unsatisfied. Consequently, considering the poor prognosis and limitation of the ccRCC patients, it is critical to construct a more credible and adaptable predictive model to evaluate the prognosis effectively and facilitate optimal therapeutic alternatives.
medicine, general & internal
What problem does this paper attempt to address?